Moreover, the mutation of miR-196A2/RS11614913 is associated with the risk of BD by reducing the expression of miR-196a and increasing the secretion of the target protein Bach1 as well as the proinflammatory IL-1β and McP-1 cytokines (Qi et al., 2013). Here, IL1B is linked to Behcet disease.